A comparative study of gastric adenocarcinoma HER2 IHC phenotype and mass spectrometry-based quantification

A comparative study of gastric adenocarcinoma HER2 IHC phenotype and mass spectrometry-based quantification

IntroductionGastric cancer is a highly heterogeneous malignant tumor of the digestive system. Anti-HER2 treatment can inhibit downstream signaling pathways and improve clinical treatment and outcomes in patients with HER2 protein overexpression. Currently, two standard methods for evaluating HER2 ex...

Full description

Bibliographic Details
Main Authors: Bin Xu, Hui Chen, Jingjing Zhang, Yanghai Cong, Li Ning, Limin Chen, Yushi Zhang, Yong Zhang, Zhanchun Song, Yuan Meng, Lianqi He, Wei-li Liao, Ying Lu, Fengyi Zhao
Format: Article
Language:English
Published: Frontiers Media S.A. 2023-06-01
Series:Frontiers in Oncology
Subjects:
gastric cancer
mixed classification
HER2
IHC
MS-SRM
types identification
Online Access:https://www.frontiersin.org/articles/10.3389/fonc.2023.1152895/full

Internet

https://www.frontiersin.org/articles/10.3389/fonc.2023.1152895/full

Similar Items